MCAM and cancer: They developed a highly specific anti-CD146 mAb (YY146) and presented noninvasive PET imaging of CD146 expression in vivo in mice (Fig. 13), envisaging the potential of this novel mAb for targeted cancer diagnostics and/or therapy.